Sinéad Cuffe

17.8k citations

102 papers · 11.1k indexed · 3 hit papers · h-index 27

Impact in

Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in

Oncology 50
- Cancer Immunotherapy and Biomarkers 15
- Colorectal Cancer Treatments and Studies 8
- Cancer Cells and Metastasis 7
Cancer Research 23
- Cancer Genomics and Diagnostics 12

Co-authors: Ali Tafreshi Rina Hui Julie R. Brahmer Maya Gottfried Nir Peled Katsuyuki Hotta Tibor Csőszi Suman Rao
Journals: Journal of Clinical Oncology (22 papers)Journal of Thoracic Oncology (20 papers)Lung Cancer (7 papers)Annals of Oncology (6 papers)Cancer Treatment Reviews (3 papers)
Partner nations: Ireland Canada United States

In The Last Decade

Sinéad Cuffe

97 papers receiving 10.9k citations

Hit Papers

align trajectories log scale

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% 2021 · 616 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Oncology
2019 Journal of Clinical Oncology
2016 New England Journal of Medicine

Peers

Countries citing papers authored by Sinéad Cuffe

Since Specialization

Citations

This map shows the geographic impact of Sinéad Cuffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinéad Cuffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinéad Cuffe more than expected).

Fields of papers citing papers by Sinéad Cuffe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sinéad Cuffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinéad Cuffe. The network helps show where Sinéad Cuffe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sinéad Cuffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sinéad Cuffe Line = papers co-authored together Sinéad Cuffe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feasibility Randomised Control Trial of OptiMal: A Self-Management Intervention for Cancer Survivors Current Oncology ·高山一生, Kathleen Bennett, Sinéad Cuffe, Clíona Grant, Megan Kennedy, Deirdre Connolly	2023	0
2	Acute kidney Injury due to Alectinib, an Anaplastic Lymphoma Kinase inhibitor 林正德, Frederic C. Haupt, Angela Bibiana Nieto Rodríguez, Sinéad Cuffe, Brendan Doyle, Brenda Walker Griffin, Donal J. Sexton	2021	0
3	Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC Cancers ·Gillian Moore, Evelyn Worboys, Keith E Hainan, Lauren Brady, Siobhan Nicholson, Ronan Ryan, Katie E. O’Sullivan, Kenneth J. O’Byrne, Carmen Blanco‐Aparicio, Sinéad Cuffe, Michael F. O‘Neill, Susan Heavey, Stephen P. Finn, Kathy Gately	2021	8
4	Vaping and lung cancer – A review of current data and recommendations Lung Cancer ·Dara Bracken‐Clarke, 汪尧进, Anne‐Marie Baird, Paul Buchanan, Kathy Gately, Sinéad Cuffe, Stephen P. Finn	2021	79
5	Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study Gastric Cancer ·Wasat Mansoor, Hendrik‐Tobias Arkenau, María Alsina, Kohei Shitara, Peter Thuss‐Patience, Sinéad Cuffe, Mikhail Dvorkin, Jae‐Hyun Park, Takayuki Ando, Marc Van den Eynde, Giordano Beretta, Alberto Zaniboni, Toshihiko Doi, Josep Tabernero, David H. Ilson, Lukas Makris, Karim A. Benhadji, Eric Van Cutsem	2021	6
6	Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer Pharmacology & Therapeutics ·Vishnu Priya V., 何立波, Nathalie Simon, Susan Heavey, Sinéad Cuffe, Stephen P. Finn, Gillian Moore, Kathy Gately	2019	28
7	OA14.01 KEYNOTE-024 3-Year Survival Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer Journal of Thoracic Oncology ·Martin Reck, Delvys Rodríguez‐Abreu, 早瀬麻子, Rina Hui, Tibor Csőszi, András Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Tamás Garay, E. Jensen, Victoria Ebiana, Julie R. Brahmer	2019	29
8	P1.02-065 Elucidating the Role of PIM Kinase and Its Therapeutic Potential in NSCLC Journal of Thoracic Oncology ·Gillian Moore, Susan Heavey, Evelyn Worboys, Lauren Brady, Kenneth J. O’Byrne, Stephen P. Finn, Sinéad Cuffe, Michael F. O‘Neill, Kathy Gately	2017	1
9	PL04a.01: Health-Related Quality of Life for Pembrolizumab vs Chemotherapy in Advanced NSCLC with PD-L1 TPS ≥50%: Data from KEYNOTE-024 Journal of Thoracic Oncology ·Julie R. Brahmer, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Anne C. Deitz, Gregory M. Lubiniecki, Jin Zhang, Reshma Rangwala, Martin Reck	2017	10
10	P1.05-021 circRNAs: Potential Novel Biomarkers for the Early Detection of Lung Cancer Journal of Thoracic Oncology ·Ruby C.Y. Lin, Glen Reid, Luciano Mutti, Anthony G. Ryan, Siobhan Nicholson, Niamh Leonard, Vincent Young, Ronan Ryan, Stephen P. Finn, Sinéad Cuffe, Steven G. Gray	2017	2
11	P3.02c-030 Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC) Journal of Thoracic Oncology ·Edward B. Garon, Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, David C. Turner, Julie A. Stone, Reshma Rangwala, Julie R. Brahmer	2017	1
12	Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial The Lancet Oncology ·Julie R. Brahmer, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Jin Zhang, Gregory M. Lubiniecki, Anne C. Deitz, Reshma Rangwala, Martin Reck	2017	255
13	ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients Cancer Epidemiology ·Sinéad Cuffe, Abul Kalam Azad, 正子山西, Xin Qiu, Yonathan Brhane, Qin Kuang, Sharon Marsh, Sevtap Savas, Zhuo Chen, Dangxiao Cheng, Natasha B. Leighl, Glenwood D. Goss, Scott A. Laurie, Lesley Seymour, Penelope A. Bradbury, Frances A. Shepherd, Ming‐Sound Tsao, Bingshu E. Chen, Wei Xu, Geoffrey Liu	2016	7
14	Lung cancer stem cells: The root of resistance Lauren MacDonagh, Steven G. Gray, Eamon P. Breen, Sinéad Cuffe, Stephen P. Finn, Kenneth J. O’Byrne, Martin P. Barr	2016	2
15	Insomnia prevalence in an oncology patient population: an Irish tertiary referral centre experience Annals of Oncology ·Erica Barato, Federico Gonzalez del Campo, Atanasia Wambui Maingi, H. Klueter, Min Yuen Teo, Soon Tjin Lim, Eimear Duff, Weiting Zhu, John Kennedy, D. O’Donnell, 高太忠, Clíona Grant, David Gallagher, F. Labhardt, 雅記岩名, Anne-Marie O’Dwyer, Sinéad Cuffe	2016	1
16	KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced NSCLC with a PD-L1 tumor proportion score (TPS) ≥50% Annals of Oncology ·Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, András Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Melanie A. Leiby, Gregory M. Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R. Brahmer	2016	12
17	A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC) Lung Cancer ·Abul Kalam Azad, Xin Qiu, Kevin Boyd, Qin Kuang, Marjan Emami, Akbaningrum Fatmawati, H. Cameron, Devalben Patel, Zhuo Chen, Dangxiao Cheng, Ronald Feld, Natasha B. Leighl, Frances A. Shepherd, Ming‐Sound Tsao, Wei Xu, Geoffrey Liu, Sinéad Cuffe	2014	10
18	Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing Pharmacogenetics and Genomics ·Sinéad Cuffe, Lesli C. Myers, Xin Qiu, Débora Füchter, Theodoros Varouxis, Bradley De Souza, Harisman Harisman, R. B., Abul Kalam Azad, B. Grote, Luis A. Sanchez, Natasha B. Leighl, Shabbir M.H. Alibhai, Wei Xu, Amalia M. Issa, Geoffrey Liu	2014	28
19	The emerging role of microRNAs in resistance to lung cancer treatments Cancer Treatment Reviews ·Lauren MacDonagh, Steven G. Gray, Stephen P. Finn, Sinéad Cuffe, Kenneth J. O’Byrne, Martin P. Barr	2014	79
20	Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers Journal of Thoracic Oncology ·Sinéad Cuffe, Teng Moua, Mariane Brascher Elizeire, Heidi Roberts, James R. Jett, Frances A. Shepherd	2011	31

About Sinéad Cuffe

Sinéad Cuffe is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Gastroenterology and Hepatology, having authored 102 papers that have together received 11.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Diagnosis and Treatment (14 papers), Cancer Genomics and Diagnostics (12 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Cells and Metastasis (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Mechanisms and Therapy (7 papers). The work is most often cited by research in Oncology (8.6k citations), Pulmonary and Respiratory Medicine (5.8k citations), Cancer Research (1.7k citations), Immunology (1.9k citations) and Pathology and Forensic Medicine (540 citations). Sinéad Cuffe has collaborated with scholars based in Ireland, Canada and United States. Frequent co-authors include Ali Tafreshi, Rina Hui, Julie R. Brahmer, Maya Gottfried, Nir Peled, Katsuyuki Hotta, Tibor Csőszi, Suman Rao, Delvys Rodríguez‐Abreu and Andrew Robinson. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer, Annals of Oncology and Cancer Treatment Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact